| dc.contributor.author | Simões Silva, Rodrigo | |
| dc.contributor.author | Alfonso Ruiz Díaz, Jorge Javier | |
| dc.contributor.author | Gómez Garay, Ana Fidelina | |
| dc.contributor.author | Sobrinho, Juliana C. | |
| dc.contributor.author | Kayano, Anderson M. | |
| dc.contributor.author | de Medeiros, Daniel S.S. | |
| dc.contributor.author | Teles, Carolina B.G. | |
| dc.contributor.author | Quintero, Arístides | |
| dc.contributor.author | Fuly, André L. | |
| dc.contributor.author | Vega Gómez, María Celeste | |
| dc.contributor.author | Pereira, Soraya S. | |
| dc.contributor.author | da Silva, Saulo L. | |
| dc.contributor.author | Stábeli, Rodrigo G. | |
| dc.contributor.author | Soares, Andreimar M. | |
| dc.date.accessioned | 2025-06-18T12:37:13Z | |
| dc.date.available | 2025-06-18T12:37:13Z | |
| dc.date.issued | 2021-07-21 | |
| dc.identifier.citation | Simões-Silva, R., Alfonso, J. J., Gómez, A. F., Sobrinho, J. C., Kayano, A. M., de Medeiros, D. S. S., Teles, C. B. G., Quintero, A., Fuly, A. L., Vega Gómez, C., Pereira, S. S., da Silva, S. L., Stábeli, R. G., & Soares, A. M. (2021). Synergism of in vitro plasmodicidal activity of phospholipase A2 isoforms isolated from panamanian Bothrops asper venom. Chemico-Biological Interactions, 346, Article 109581.
https://doi.org/10.1016/j.cbi.2021.109581 | en |
| dc.identifier.issn | 0009-2797 | es |
| dc.identifier.other | https://doi.org/10.1016/j.cbi.2021.109581 | es |
| dc.identifier.uri | http://hdl.handle.net/20.500.14066/4592 | |
| dc.description | Corresponding author. Fiocruz Rondonia, Rua da Beira, 7176, Bairro Lagoa, 76812, Porto Velho, Rondonia, Brazil. E-mail address: andreimar.soares@fiocruz.br (A.M. Soares). | en |
| dc.description.abstract | Bothrops asper is one of the most important snake species in Central America, mainly because of its medical importance in countries like Ecuador, Panama and Costa Rica, where this species causes a high number of snakebite accidents. Several basic phospholipases A2 (PLA2s) have been previously characterized from B. asper venom, but few studies have been carried out with its acidic isoforms. In addition, since snake venom is a rich source of bioactive substances, it is necessary to investigate the biotechnological potential of its components. In this context, this study aimed to carry out the biochemical characterization of PLA2 isoforms isolated from B. asper venom and to evaluate the antiparasitic potential of these toxins. The venom and key fractions were subjected to different chromatographic steps, obtaining nine PLA2s, four acidic ones (BaspAc-I, BaspAc-II, BaspAc-III and BaspAc-IV) and five basic ones (BaspB-I, BaspB-II, BaspB-III, BaspB-IV and BaspB-V). The isoelectric points of the acidic PLA2s were also determined, which presented values ranging between 4.5 and 5. The findings indicated the isolation of five unpublished isoforms, four Asp49-PLA, corresponding to the group of acidic isoforms, and one Lys49-PLA2-like. Acidic PLA2s catalyzed the degradation of all substrates evaluated; however, for the basic PLA2s, there was a preference for phosphatidylglycerol and phosphatidic acid. The antiparasitic potential of the toxins was evaluated, and the acidic PLA2s demonstrated action against the epimastigote forms of T. cruzi and promastigote forms of L. infantum, while the basic PLA2s BaspB-II and BaspB-IV showed activity against P. falciparum. The results indicated an increase of up to 10 times in antiplasmodial activity, when the Asp49-PLA2 and Lys49-PLA2 were associated with one another, denoting synergistic action between these PLA2 isoforms. These findings correspond to the first report of synergistic antiplasmodial action for svPLA2s, demonstrating that these molecules may be important targets in the search for new antiparasitic agents. | es |
| dc.description.sponsorship | Consejo Nacional de Ciencia y Tecnología | es |
| dc.format.extent | 14 páginas | es |
| dc.language.iso | eng | es |
| dc.publisher | Elsevier | es |
| dc.subject.mesh | Alineación de secuencia | es |
| dc.subject.mesh | Antiprotozoarios | es |
| dc.subject.mesh | Bothrops | es |
| dc.subject.mesh | Fosfolipasas A2 | es |
| dc.subject.mesh | Isoformas de proteínas | es |
| dc.subject.mesh | Leishmania infantum | es |
| dc.subject.mesh | Pruebas de sensibilidad parasitaria | es |
| dc.subject.mesh | Punto isoeléctrico | es |
| dc.subject.mesh | Secuencia de aminoácidos | es |
| dc.subject.mesh | Sinergismo farmacológico | es |
| dc.subject.mesh | Venenos de serpiente | es |
| dc.subject.mesh | Sequence alignment | en |
| dc.subject.mesh | Antiprotozoal agents | en |
| dc.subject.mesh | Bothrops | en |
| dc.subject.mesh | Phospholipases A2 | en |
| dc.subject.mesh | Protein isoforms | en |
| dc.subject.mesh | Leishmania infantum | en |
| dc.subject.mesh | Parasitic sensitivity tests | en |
| dc.subject.mesh | Isoelectric point | en |
| dc.subject.mesh | Amino acid sequence | en |
| dc.subject.mesh | Drug synergism | en |
| dc.subject.mesh | Snake venoms | en |
| dc.subject.other | Antiparasitic activity | es |
| dc.subject.other | Bothrops asper | es |
| dc.subject.other | Phospholipases A(2) | es |
| dc.subject.other | Snake venom | es |
| dc.subject.other | Synergism | es |
| dc.title | Synergism of in vitro plasmodicidal activity of phospholipase A2 isoforms isolated from panamanian Bothrops asper venom | es |
| dc.type | info:eu-repo/semantics/article | es |
| dc.type | info:eu-repo/semantics/publishedVersion | es |
| dc.identifier.doi | 10.1016/j.cbi.2021.109581 | es |
| dc.description.fundingtext | Programa Paraguayo para el Desarrollo de la Ciencia y Tecnología. Programa Nacional de Incentivo a los Investigadores | es |
| dc.description.fundingtext | Programa Paraguayo para el Desarrollo de la Ciencia y Tecnología. Programa de Repatriación y Radicación de Investigadores del Exterior | es |
| dc.identifier.essn | 1872-7786 | es |
| dc.journal.title | Chemico-Biological Interactions | es |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
| dc.rights.copyright | © 2021 Elsevier B.V. This article is made available under the Elsevier license (http://www.elsevier.com/open-access/userlicense/1.0/). | es |
| dc.volume.number | 346 | es |